Orally administered yeast‐derived β‐glucan alleviates mast cell‐dependent airway hyperresponsiveness and inflammation in a murine model of asthma

Documenti analoghi

• Intermittent hypoxic pretreatment exacerbates house dust mite‐induced asthma airway inflammation
  di: Hao Meng, et al.
  Pubblicazione: (2024)
• Combined application of mesenchymal stem cells and different glucocorticoid dosing alleviates osteoporosis in SLE murine models
  di: Sisi Ding, et al.
  Pubblicazione: (2024)
• Evaluating the Toxocara cati extract as a therapeutic agent for allergic airway inflammation
  di: Amin Bakhshani, et al.
  Pubblicazione: (2024)
• Association of IL‐33 in modeling type‐2 airway inflammation and pulmonary emphysema in mice
  di: Chika Miyaoka, et al.
  Pubblicazione: (2024)
• Succinate coenzyme A ligase β‐like protein from Trichinella spiralis is a potential therapeutic molecule for allergic asthma
  di: Kalibixiati Aimulajiang, et al.
  Pubblicazione: (2024)